ey0019.9-4 | Metabolic risk in childhood cancer | ESPEYB19
E Muhic
, S Mathiesen
, MM Nielsen
, A Suominen
, K Sorensen
, M Ifversen
, RL Nolsoe
, KM Pedersen
, P Lahteenmaki
, BG Nordestgaard
, A Juul
, K Jahnukainen
, K Muller
klaus.mueller@regionh.dk Transplant Cell Ther. 2021 Sep;27(9): 778.e1-778.e8. PMID: 34091072.Brief Summary: Several studies in cancer survivors have reported an increased prevalence of metabolic syndrome (MetS), which is often observed in the absence of overt obesity. Data about MetS in survivors of pediatric hematopoietic stem cell transplantation (HSCT) are scarce. This cross-sectional cohort study...